Clinical Trial Update: Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 trial evaluating the efficacy and safety of Tezepelumab for eosinophilic esophagitis. The study is sponsored by As…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Eosinophilic Esophagitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING